Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

Ovalum Ltd. releases for marketing the TraVerse™ micro-catheter in the US.

Ovalum Ltd. releases for marketing the TraVerse™ micro-catheter in the US. The TraVerse™ micro-catheter is a unique stainless steel helically laser cut support and exchange catheter used to aid guide wire manipulation in complex angiographic procedures.

Rehovot, Israel (PRWEB) March 1, 2008 -- Following approval in Europe, the TraVerse™ micro-catheter will be marketed separately from the CiTop™ guidewire system previously approved for sale in the European Economic Community and cleared for sale in the US by FDA.

The TraVerse™ micro-catheter is a unique stainless steel helically laser cut support and exchange catheter used to aid guide wire manipulation in complex angiographic procedures. In addition it can be used for injection of contrast media for visualization of target lesions.

Noam Shamay, founder and Ovalum Ltd. Chief executive officer, said: "this is a major millstone for us; the unique benefit of the TraVerse™ micro-catheter is the physician ability to shape its tip to facilitate complex navigation of wires. An additional benefit of the TraVerse™ micro-catheter is its extraordinary pushability in comparison to polymeric catheters currently on the market; this can be helpful in situations like failed crossings of balloon catheters in calcified lesions. This is one of the lowest profile micro-catheters on the market with an outside diameter of 0.025" and inside diameter of 0.019". I believe the Traverse™ will be an important player in every cath lab with a very competitive price.

In addition, we have presented excellent "first in man" clinical results of the ExPander™ coronary guidewire last week at the CRF - CTO Summit in New York and we expect to gain regulatory clearance this year for this important coronary guidewire."

About Ovalum
Ovalum Ltd. Is a privately held medical device company established in 2005 to develop and produce safe and effective technology designed specifically for the most challenging arterial conditions.

The CiTop™ Guidewire system is a 0.014" high-end guidewire with a dilatable tip specifically designed for CTO recanalization. The system is made of a highly flexible guidewire body and a distal tip consisting of a working element with dilating capabilities to facilitate wire cross-over.
The CiTop™ Guidewire is available in both 6gr and 10gr degrees of stiffness, to address the broad range of artery sizes and occlusion hardness present in Peripheral Artery disease (PAD) patients anatomy.

A guidewire is a mandatory tool which provides exclusive access to minimally invasive treatments. In order to use balloon catheters and stent delivery systems minimally invasive specialists all need a guidewire to cross the lesion first.

CTO have continuously presented some of the more difficult challenges to interventional cardiologists and radiologists.

Ovalum`s CTO solutions, the CiTop™ Guidewire system the CiTop™ CoBra™ guidewire and the TraVerse™ micro-catheter enables the minimally invasive intervention specialist to cross over the arterial blockage in a controllable and reproducible way.

CiTop™, CoBra™, TraVerse ™ and ExPander™ are trademarks of Ovalum Ltd.

###

Simillar Articles

Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire
Following First-in-Man study success, Ovalum Ltd. launches a multicenter study using the CiTop™ technology in the coronary arteries. Ovalum Ltd., a privately held Israeli medical device...
Ovalum Ltd. Received Clearance to Market the CiTop™ Product-Line in Israel
Following FDA clearance and CE approval, revolutionary CiTop™ product-line is now available in Israel. Ovalum Ltd., a privately held Israeli medical device company, has announced today the...
Ovalum Ltd., Announced the First US Procedures Using the Revolutionary CiTop™ Guidewire System
The procedures will be performed at the Washington Hospital Center (WHC) in Washington DC by Dr. Nelson L. Bernardo.
CoreValve's 18-French ReValving(TM) System for percutaneous aortic valve replacement (PAVR)...
CoreValve ( www.corevalve.com ) announced today that its third-generation, proprietary aortic heart valve was implanted successfully -- non-surgically -- in a 'high-risk' patient suffering from...
Citra Anticoagulants Signs Exclusive Distribution Agreement with HAEMO-Pro for LOXXIT™...
Citra Anticoagulants, Inc. reported that they signed a distribution agreement with HAEMO-Pro to distribute LOXXIT™ Catheter Lock Solution in Germany.
Home Terms of Use Privacy Policy Contact Us